A medical innovation that has significantly advanced medical treatments, magnetic resonance imaging has helped doctors see ...

Contrast agent linked with brain abnormalities on MRI Date: December 17, 2013 Source: Radiological Society of North America Summary: For the first time, researchers have confirmed an association ...

A team led by Eamon Doyle, Ph.D., in the Borzage Laboratory at Children's Hospital Los Angeles developed novel computational ...

In his efforts to create a contrast agent especially suited for use in vascular cells of the so-called blood-brain barrier, the physicist was able to draw on preliminary work undertaken by his FMP ...

Direct evidence of gadolinium deposition in brain tissues following contrast-enhanced MRI exams Date: March 16, 2015 Source: Mayo Clinic Summary: New research finds direct evidence of gadolinium ...

Ultimately, across three free-standing pediatric institutions, the base case cost for a sedated noncontrast outpatient brain MRI was $842 ($775–924 across hospitals), for a nonsedated MRI was ...

The researchers tested the method in cultures of brain and prostate cancer cells and in mice. For most MRI probes, the signal from the tumor is up to twice as strong as from normal tissue – a “tumor ...

The FDA has approved Elucirem, a macrocyclic gadolinium-based contrast agent for those aged 2 years and older, for use in contrast-enhanced MRIs The product, Guerbet’s gadopiclenol, was ...

A commonly used MRI contrast agent has been associated with brain abnormalities, new research suggests. A study conducted by investigators from the University School of Medicine in Tokyo and the ...